Cara Therapeutics Inc

Research Cara Therapeutics Inc (TVRD) on Bullrun: market cap USD 17.92M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 17.92M.

About Cara Therapeutics Inc

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States.

Frequently asked questions

What is Cara Therapeutics Inc's market cap?

Cara Therapeutics Inc's market capitalization is USD 17.92M.

What does Cara Therapeutics Inc do?

Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the...